
Jerry D. Johnson
Examiner (ID: 10315, Phone: (571)272-1448 , Office: P/3991 )
| Most Active Art Unit | 1111 |
| Art Unit(s) | 1764, 1612, 1107, 1111, 1108, 1811, 1109, 1721, 3991, 2899 |
| Total Applications | 1366 |
| Issued Applications | 976 |
| Pending Applications | 80 |
| Abandoned Applications | 310 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6349355
[patent_doc_number] => 20100249032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'Human EPO Mimetic Hinge Core Mimetibodies, Compositions, Methods and Uses'
[patent_app_type] => utility
[patent_app_number] => 12/718147
[patent_app_country] => US
[patent_app_date] => 2010-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 176
[patent_figures_cnt] => 176
[patent_no_of_words] => 35615
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12718147
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/718147 | Human EPO Mimetic Hinge Core Mimetibodies, Compositions, Methods and Uses | Mar 4, 2010 | Abandoned |
Array
(
[id] => 6614568
[patent_doc_number] => 20100310511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'DETERMINING DISEASE OR IMMUNE SYSTEM FEATURES BASED ON ANALYSIS OF IMMUNE SYSTEM CHARACTERISTICS'
[patent_app_type] => utility
[patent_app_number] => 12/718905
[patent_app_country] => US
[patent_app_date] => 2010-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9714
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0310/20100310511.pdf
[firstpage_image] =>[orig_patent_app_number] => 12718905
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/718905 | DETERMINING DISEASE OR IMMUNE SYSTEM FEATURES BASED ON ANALYSIS OF IMMUNE SYSTEM CHARACTERISTICS | Mar 4, 2010 | Abandoned |
Array
(
[id] => 9951142
[patent_doc_number] => 08999930
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-07
[patent_title] => 'Soluble hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same'
[patent_app_type] => utility
[patent_app_number] => 12/711564
[patent_app_country] => US
[patent_app_date] => 2010-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 15858
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12711564
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/711564 | Soluble hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same | Feb 23, 2010 | Issued |
Array
(
[id] => 6437981
[patent_doc_number] => 20100152704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'Method for Intravesical Drug Delivery'
[patent_app_type] => utility
[patent_app_number] => 12/709551
[patent_app_country] => US
[patent_app_date] => 2010-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10189
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20100152704.pdf
[firstpage_image] =>[orig_patent_app_number] => 12709551
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/709551 | Method for intravesical drug delivery | Feb 21, 2010 | Issued |
Array
(
[id] => 7711795
[patent_doc_number] => 20120004160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'METHODS FOR IDENTIFYING AND COMPOUNDS USEFUL FOR THE DIAGNOSIS AND TREATMENT OF DISEASES INVOLVING INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 13/202569
[patent_app_country] => US
[patent_app_date] => 2010-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 21040
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13202569
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/202569 | METHODS FOR IDENTIFYING AND COMPOUNDS USEFUL FOR THE DIAGNOSIS AND TREATMENT OF DISEASES INVOLVING INFLAMMATION | Feb 17, 2010 | Abandoned |
Array
(
[id] => 6248677
[patent_doc_number] => 20100137195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'Production of Recombinant IL-18 Binding Protein'
[patent_app_type] => utility
[patent_app_number] => 12/705773
[patent_app_country] => US
[patent_app_date] => 2010-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14373
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137195.pdf
[firstpage_image] =>[orig_patent_app_number] => 12705773
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/705773 | Production of Recombinant IL-18 Binding Protein | Feb 14, 2010 | Abandoned |
Array
(
[id] => 8538196
[patent_doc_number] => 08313916
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-20
[patent_title] => 'KID31 and antibodies that bind thereto'
[patent_app_type] => utility
[patent_app_number] => 12/705577
[patent_app_country] => US
[patent_app_date] => 2010-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 22431
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12705577
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/705577 | KID31 and antibodies that bind thereto | Feb 12, 2010 | Issued |
Array
(
[id] => 6431076
[patent_doc_number] => 20100143369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'Interferon Alpha Receptor I Antibodies And Their Use'
[patent_app_type] => utility
[patent_app_number] => 12/704948
[patent_app_country] => US
[patent_app_date] => 2010-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 30509
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143369.pdf
[firstpage_image] =>[orig_patent_app_number] => 12704948
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/704948 | Interferon alpha receptor I antibodies and their use | Feb 11, 2010 | Issued |
Array
(
[id] => 7810957
[patent_doc_number] => 08133487
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-13
[patent_title] => 'Soluble heterodimeric cytokine receptor'
[patent_app_type] => utility
[patent_app_number] => 12/695069
[patent_app_country] => US
[patent_app_date] => 2010-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 13705
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/133/08133487.pdf
[firstpage_image] =>[orig_patent_app_number] => 12695069
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/695069 | Soluble heterodimeric cytokine receptor | Jan 26, 2010 | Issued |
Array
(
[id] => 8577532
[patent_doc_number] => 08343742
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-01
[patent_title] => 'Encapsulation of cells in biologic compatible scaffolds by coacervation of charged polymers'
[patent_app_type] => utility
[patent_app_number] => 12/693300
[patent_app_country] => US
[patent_app_date] => 2010-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 10840
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12693300
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/693300 | Encapsulation of cells in biologic compatible scaffolds by coacervation of charged polymers | Jan 24, 2010 | Issued |
Array
(
[id] => 9944423
[patent_doc_number] => 08993725
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-31
[patent_title] => 'Notch-based fusion proteins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/657573
[patent_app_country] => US
[patent_app_date] => 2010-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 69
[patent_no_of_words] => 14038
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12657573
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/657573 | Notch-based fusion proteins and uses thereof | Jan 20, 2010 | Issued |
Array
(
[id] => 6228815
[patent_doc_number] => 20100183553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'Composition and Methods for Affecting Metallocorrinoid Uptake'
[patent_app_type] => utility
[patent_app_number] => 12/646249
[patent_app_country] => US
[patent_app_date] => 2009-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7033
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20100183553.pdf
[firstpage_image] =>[orig_patent_app_number] => 12646249
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/646249 | Composition and Methods for Affecting Metallocorrinoid Uptake | Dec 22, 2009 | Abandoned |
Array
(
[id] => 7484510
[patent_doc_number] => 20110250208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'Oxidized Cardiolipin as a Novel Pro-Inflammatory Factor'
[patent_app_type] => utility
[patent_app_number] => 13/140906
[patent_app_country] => US
[patent_app_date] => 2009-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 12877
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20110250208.pdf
[firstpage_image] =>[orig_patent_app_number] => 13140906
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/140906 | Oxidized Cardiolipin as a Novel Pro-Inflammatory Factor | Dec 20, 2009 | Abandoned |
Array
(
[id] => 6245440
[patent_doc_number] => 20100135957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'Chimeric Heteromultimer Adhesins'
[patent_app_type] => utility
[patent_app_number] => 12/639822
[patent_app_country] => US
[patent_app_date] => 2009-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 23406
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20100135957.pdf
[firstpage_image] =>[orig_patent_app_number] => 12639822
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/639822 | ErbB2 and ErbB3 chimeric heteromultimer receptors | Dec 15, 2009 | Issued |
Array
(
[id] => 6247187
[patent_doc_number] => 20100136588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'Methods and Devices for Diagnosis of Appendicitis'
[patent_app_type] => utility
[patent_app_number] => 12/638743
[patent_app_country] => US
[patent_app_date] => 2009-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22065
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20100136588.pdf
[firstpage_image] =>[orig_patent_app_number] => 12638743
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/638743 | Methods and Devices for Diagnosis of Appendicitis | Dec 14, 2009 | Abandoned |
Array
(
[id] => 8199896
[patent_doc_number] => 08187613
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-29
[patent_title] => 'Method of treating allergies using TGF-β1 and allergens'
[patent_app_type] => utility
[patent_app_number] => 12/638001
[patent_app_country] => US
[patent_app_date] => 2009-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 14
[patent_no_of_words] => 4720
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/187/08187613.pdf
[firstpage_image] =>[orig_patent_app_number] => 12638001
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/638001 | Method of treating allergies using TGF-β1 and allergens | Dec 14, 2009 | Issued |
Array
(
[id] => 8188362
[patent_doc_number] => 08182822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-22
[patent_title] => 'Method of treating allergies using TGF-β1 and allergens'
[patent_app_type] => utility
[patent_app_number] => 12/638019
[patent_app_country] => US
[patent_app_date] => 2009-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 14
[patent_no_of_words] => 4720
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/182/08182822.pdf
[firstpage_image] =>[orig_patent_app_number] => 12638019
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/638019 | Method of treating allergies using TGF-β1 and allergens | Dec 14, 2009 | Issued |
Array
(
[id] => 6412718
[patent_doc_number] => 20100166768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'High Affinity Human Antibodies to PCSK9'
[patent_app_type] => utility
[patent_app_number] => 12/637942
[patent_app_country] => US
[patent_app_date] => 2009-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21761
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20100166768.pdf
[firstpage_image] =>[orig_patent_app_number] => 12637942
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/637942 | High affinity human antibodies to PCSK9 | Dec 14, 2009 | Issued |
Array
(
[id] => 6228902
[patent_doc_number] => 20100183640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF FIBROTIC CONDITIONS AND IMPAIRED LUNG FUNCTION AND TO ENHANCE LYMPHOCYTE PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 12/637573
[patent_app_country] => US
[patent_app_date] => 2009-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 28055
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20100183640.pdf
[firstpage_image] =>[orig_patent_app_number] => 12637573
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/637573 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF FIBROTIC CONDITIONS AND IMPAIRED LUNG FUNCTION AND TO ENHANCE LYMPHOCYTE PRODUCTION | Dec 13, 2009 | Abandoned |
Array
(
[id] => 6380034
[patent_doc_number] => 20100316628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'AGENTS AND METHODS FOR TREATING RESPIRATORY DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/634432
[patent_app_country] => US
[patent_app_date] => 2009-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 21229
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0316/20100316628.pdf
[firstpage_image] =>[orig_patent_app_number] => 12634432
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/634432 | AGENTS AND METHODS FOR TREATING RESPIRATORY DISORDERS | Dec 8, 2009 | Abandoned |